收费全文 | 1115312篇 |
免费 | 75989篇 |
国内免费 | 3189篇 |
耳鼻咽喉 | 14783篇 |
儿科学 | 34237篇 |
妇产科学 | 30305篇 |
基础医学 | 153474篇 |
口腔科学 | 28688篇 |
临床医学 | 97121篇 |
内科学 | 228081篇 |
皮肤病学 | 22038篇 |
神经病学 | 93258篇 |
特种医学 | 45610篇 |
外国民族医学 | 349篇 |
外科学 | 175762篇 |
综合类 | 21383篇 |
现状与发展 | 1篇 |
一般理论 | 421篇 |
预防医学 | 79895篇 |
眼科学 | 25144篇 |
药学 | 78047篇 |
1篇 | |
中国医学 | 2106篇 |
肿瘤学 | 63786篇 |
2021年 | 10746篇 |
2019年 | 11058篇 |
2018年 | 14632篇 |
2017年 | 11251篇 |
2016年 | 12182篇 |
2015年 | 13992篇 |
2014年 | 20038篇 |
2013年 | 29607篇 |
2012年 | 41457篇 |
2011年 | 43787篇 |
2010年 | 25845篇 |
2009年 | 24318篇 |
2008年 | 40684篇 |
2007年 | 43045篇 |
2006年 | 42758篇 |
2005年 | 42113篇 |
2004年 | 40164篇 |
2003年 | 38149篇 |
2002年 | 37112篇 |
2001年 | 43139篇 |
2000年 | 43883篇 |
1999年 | 38095篇 |
1998年 | 12487篇 |
1997年 | 11174篇 |
1996年 | 10825篇 |
1995年 | 10026篇 |
1994年 | 9475篇 |
1993年 | 8926篇 |
1992年 | 29081篇 |
1991年 | 27818篇 |
1990年 | 27126篇 |
1989年 | 25998篇 |
1988年 | 24148篇 |
1987年 | 23721篇 |
1986年 | 22816篇 |
1985年 | 21761篇 |
1984年 | 16613篇 |
1983年 | 14184篇 |
1982年 | 9040篇 |
1979年 | 15013篇 |
1978年 | 10663篇 |
1977年 | 9035篇 |
1976年 | 8535篇 |
1975年 | 9238篇 |
1974年 | 10974篇 |
1973年 | 10419篇 |
1972年 | 9818篇 |
1971年 | 9056篇 |
1970年 | 8684篇 |
1969年 | 8099篇 |
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献Areas covered: This review provides an overview of existing pharmacotherapy for osteoporosis in women and explore state-of–the-art and emerging therapies to prevent bone loss, with an emphasis on the mechanism of action, indications and side effects.
Expert opinion: Bisphosphonates appear to be a reliable and cost-effective option, whereas denosumab has introduced a simpler dosing regimen and may achieve a linear increase in bone mineral density (BMD) with no plateau being observed, along with continuous anti-fracture efficacy. Abaloparatide, a parathyroid-hormone-related peptide (PTHrP)-analogue, approved by the FDA in April 2017, constitutes the first new anabolic osteoporosis drug in the US for nearly 15 years and has also proven its anti-fracture efficacy. Romosozumab, a sclerostin inhibitor, which induces bone formation and suppresses bone resorption, has also been developed and shown a significant reduction in fracture incidence; however, concerns have arisen with regard to increased cardiovascular risk. 相似文献